| In millions, except per share items | Jul-01-18 | Jul-02-17 | Jul-03-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 | Jun-30-11 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Manufacturing & Design Services | 236.0 | 260.5 | 282.1 | 263.9 | 246.1 | 207.9 | | |
| Engineered Components & Products | 151.1 | 147.3 | 154.6 | 136.3 | 109.1 | 75.4 | | |
| Medical | | | | | | | 110.9 | |
| Other | | | | | | | 115.6 | |
| Total revenues | 375.0 | 397.6 | 419.4 | 382.1 | 336.5 | 265.0 | 226.5 | 203.4 |
| Revenue growth [+] | -5.7% | -5.2% | 9.7% | 13.6% | 27.0% | 17.0% | 11.4% | 16.9% |
| Manufacturing & Design Services | -9.4% | -7.6% | 6.9% | 7.2% | 18.4% | | | |
| Engineered Components & Products | 2.6% | -4.7% | 13.4% | 24.9% | 44.7% | | | |
| Cost of goods sold | 295.6 | 325.7 | 339.2 | 307.3 | 271.6 | 219.2 | 187.5 | 170.2 |
| Gross profit | 79.4 | 71.9 | 80.1 | 74.8 | 65.0 | 45.8 | 39.0 | 33.2 |
| Gross margin | 21.2% | 18.1% | 19.1% | 19.6% | 19.3% | 17.3% | 17.2% | 16.3% |
| Selling, general and administrative | 58.1 | 54.1 | 55.2 | 47.0 | 35.7 | 26.5 | 22.2 | 20.8 |
| Other selling, general and administrative | | | | | | | | |
| Research and development | 2.7 | 1.7 | 2.3 | 1.5 | 1.2 | 1.3 | 1.3 | 1.1 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 7.3 | 8.5 | 9.6 | 6.6 | 7.7 | 1.6 | 0.4 | -1.7 |
| EBITDA [+] | 24.4 | 22.0 | 28.7 | 31.0 | 28.6 | 21.2 | 16.8 | 14.5 |
| EBITDA growth | 10.7% | -23.4% | -7.3% | 8.5% | 34.5% | 26.2% | 15.7% | 78.5% |
| EBITDA margin | 6.5% | 5.5% | 6.9% | 8.1% | 8.5% | 8.0% | 7.4% | 7.1% |
| Depreciation | 5.9 | 5.9 | 6.1 | 4.6 | 4.7 | 3.2 | 1.4 | 1.1 |
| EBITA | 18.5 | 16.1 | 22.7 | 26.3 | 23.9 | 18.0 | 15.4 | 13.5 |
| EBITA margin | 4.9% | 4.1% | 5.4% | 6.9% | 7.1% | 6.8% | 6.8% | 6.6% |
| Amortization of intangibles | 7.3 | 8.5 | 9.6 | 6.6 | 3.4 | 1.6 | 0.4 | 0.5 |
| EBIT [+] | 11.2 | 7.6 | 13.1 | 19.8 | 20.4 | 16.5 | 15.0 | 12.9 |
| EBIT growth | 46.7% | -41.7% | -33.9% | -3.4% | 24.1% | 9.8% | 16.1% | 93.5% |
| EBIT margin | 3.0% | 1.9% | 3.1% | 5.2% | 6.1% | 6.2% | 6.6% | 6.4% |
| Non-recurring items [+] | 1.6 | | 64.9 | 2.5 | 0.2 | 0.1 | -0.1 | 16.8 |
| Asset impairment | | | 64.2 | | 0.2 | 0.1 | -0.1 | 16.9 |
| Loss (gain) on sale of assets | | | | | | | | -0.1 |
| Legal settlement | 1.6 | | | 2.5 | | | | |
| Interest expense, net [+] | 6.4 | 4.4 | 3.8 | 2.5 | 0.8 | 0.4 | 0.6 | 0.6 |
| Interest expense | 6.4 | 4.4 | 3.8 | 2.5 | 0.8 | 0.5 | 0.7 | 0.7 |
| Interest income | | | | | | 0.1 | 0.1 | 0.2 |
| Other income (expense), net [+] | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.6 | 0.4 |
| Gain (loss) on sale of assets | | | | | | | 0.1 | |
| Gain (loss) on investments | | | | | | | 0.1 | |
| Other | 0.0 | 0.1 | 0.1 | 0.2 | 4.4 | 0.2 | 0.5 | 0.4 |
| Pre-tax income | 3.2 | 3.2 | -55.5 | 15.0 | 19.6 | 16.2 | 15.1 | -3.9 |
| Income taxes | 11.4 | 1.9 | -17.2 | 4.0 | 6.6 | 2.7 | 5.3 | -11.4 |
| Tax rate | 361.4% | 59.4% | 31.0% | 26.5% | 33.7% | 16.7% | 34.9% | 289.2% |
| Net income | -8.3 | 1.3 | -38.3 | 11.0 | 13.0 | 13.5 | 9.8 | 7.5 |
| Net margin | -2.2% | 0.3% | -9.1% | 2.9% | 3.9% | 5.1% | 4.3% | 3.7% |
| |
| Basic EPS [+] | ($0.84) | $0.13 | ($3.91) | $1.11 | $1.28 | $1.32 | $0.97 | $0.73 |
| Growth | -725.3% | -103.4% | -451.5% | -13.4% | -2.8% | 36.5% | 32.5% | -2.1% |
| Diluted EPS [+] | ($0.84) | $0.13 | ($3.91) | $1.11 | $1.28 | $1.32 | $0.96 | $0.73 |
| Growth | -725.3% | -103.4% | -451.9% | -13.2% | -2.8% | 36.5% | 32.6% | -2.5% |
| |
| Shares outstanding (basic) [+] | 9.8 | 9.8 | 9.8 | 9.9 | 10.1 | 10.2 | 10.2 | 10.2 |
| Growth | 0.2% | 0.3% | -0.9% | -2.3% | -0.8% | 0.2% | -0.4% | 2.5% |
| Shares outstanding (diluted) [+] | 9.8 | 9.8 | 9.8 | 9.9 | 10.1 | 10.2 | 10.2 | 10.3 |
| Growth | 0.2% | 0.3% | -1.0% | -2.5% | -0.9% | 0.2% | -0.5% | 2.8% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |